Body and Mind to Release Q2 Fiscal Results on March 17
Body and Mind Inc. (BMMJ) announces plans to release its fiscal Q2 2022 results for the period ending January 31, 2022, on March 17, 2022, after market close. A conference call to discuss these results is scheduled for March 18, 2022, at 2 p.m. ET. BaM operates across multiple U.S. states, focusing on medical and recreational cannabis products. The company aims to enhance shareholder value through operational efficiencies, licensing, and potential mergers. Their Nevada subsidiary holds significant cultivation licenses and has received multiple awards for its cannabis strains.
- Expansion into multiple states, enhancing market presence.
- Focus on operational efficiencies likely to increase profitability.
- Award-winning cannabis strains boost brand reputation.
- None.
LAS VEGAS and VANCOUVER, BC, March 15, 2022 /PRNewswire/ - Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the "Company" or "BaM"), a multi-state US cannabis operator, is pleased to announce it intends to file results for the fiscal second quarter 2022 for the three months ending January 31, 2022, on March 17th after markets close.
The company will be hosting a conference call to discuss its results for the quarter on Friday, March 18th, 2022, at 2 p.m. ET.
Conference call details
Canada: 1-416-764-8659
North America toll-free: 1-888-664-6392
Confirmation No.: 37292270
A replay of the call will be available until March 25, 2022. The replay can be accessed as follows.
Encore replay -- Canada: 1-416-764-8677
Encore replay -- North America toll-free: 1-888-390-0541
Encore replay entry code: 292270 #
About Body and Mind Inc.
BaM is an operations focused, US multi-state cannabis operator investing in high quality medical and recreational cannabis cultivation, production and retail.
BaM continues to expand operations in Nevada, California, Arkansas, Ohio and Michigan and is dedicated to increasing shareholder value by focusing time and resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions.
Our wholly owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses and holds medical and adult-use cultivation and production licenses. BaM products include dried flower, edibles, oils and extracts as well as GPEN products. BaM cannabis strains have won numerous awards including the Las Vegas Weekly Bud Bracket, Las Vegas Hempfest Cup, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup.
Please visit www.bodyandmind.com for more information.
Instagram: @bodyandmindBaM
Twitter: @bodyandmindBaM
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes "forward-looking statements" as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans, "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved) are not statements of historical fact and should be viewed as "forward-looking statements". Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements contained in this news release and in any document referred to in this news release.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company's ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company's filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.
View original content:https://www.prnewswire.com/news-releases/body-and-mind-to-release-q2-fiscal-results-on-march-17-301502875.html
SOURCE Body and Mind Inc.
FAQ
When will Body and Mind Inc. release its Q2 fiscal results for 2022?
What is the conference call date for Body and Mind Inc. Q2 results?
What states does Body and Mind Inc. operate in?
What type of products does Body and Mind Inc. offer?
What is the stock symbol for Body and Mind Inc.?
